Iain McNeish is Chair in Oncology and Head of the Division of Cancer at Imperial College London. He is also the Director of the Ovarian Cancer Action Research Centre and Cancer theme lead in the Imperial NIHR Biomedical Research Centre (BRC). Externally, he is Chair of the NCRI Gynaecological CSG.
His research focusses on ovarian cancer, specifically developing improved therapies through improved understanding of disease biology. He leads the BriTROC translational research collaborative, investigating evolution and copy number alterations in ovarian high grade serous carcinoma. His group has also recently developed novel transplantable murine models of HGSC using CRISPR/Cas9 gene editing technology to allow investigation of novel therapies in an immunocompetent model. These transplantable cells are freely available to researchers.